(MedPage Today) -- The Trump administration will require all 50 states to explain their plans to revalidate some of their Medicaid providers in a national escalation of anti-fraud efforts that have so far largely focused on specific states, Mehmet...
(MedPage Today) -- Real-world data suggested the dual GLP-1/GIP receptor agonist tirzepatide (Mounjaro, Zepbound) was associated with greater weight loss, but also muscle loss, compared with semaglutide (Ozempic, Wegovy), according to a medical...
(MedPage Today) -- Additional antihypertensive treatment with a three-drug polypill benefitted patients after intracerebral hemorrhage (ICH), the placebo-controlled TRIDENT trial found. Among ICH survivors already on good background therapy randomized...
(MedPage Today) -- The investigational benzamide antipsychotic N-methyl amisulpride (LB-102) led to significant symptom improvement among hospitalized adults with acute schizophrenia, a randomized trial showed. In this phase II study, the mean...
(MedPage Today) -- While brand-name pantoprazole (Protonix) costs $200 for a 30-day supply on TrumpRx, the same generic prescription costs just $16.99 at Costco, Sen. Elizabeth Warren (D-Mass.) said during a hearing on the proposed HHS budget...
(MedPage Today) -- Suicide by poisoning with the common food preservative sodium nitrite and its oxidised metabolite, nitrate, is disproportionately high among young men, U.K. researchers warned. (BMJ Public Health) Meanwhile, a Canadian man facing...
(MedPage Today) -- SAN DIEGO -- Injecting the PD-1 inhibitor nivolumab (Opdivo) directly into high-risk oral precancers proved safe and reduced lesion size in the vast majority of patients enrolled in a small phase I study, allowing some to avoid...
(MedPage Today) -- Suicide deaths among adolescents and young adults declined across the U.S. after the launch of the 988 Suicide and Crisis Lifeline in 2022, according to an observational study. From July 2022 through December 2024, 35,529 suicides...
(MedPage Today) -- These days, we're overwhelmed with data. Every chart on every patient is packed full of data -- some of it incredibly useful and important, some of it just a lot of noise, some of it just copy-and-pasted and brought forward...
(MedPage Today) -- Cemdisiran, an investigational small interfering RNA (siRNA) therapy targeting complement component 5 (C5), met both its primary and a key secondary endpoint in the phase III NIMBLE trial of generalized myasthenia gravis, whether...
(MedPage Today) -- SAN DIEGO -- Clearance of circulating tumor (ct)DNA after neoadjuvant therapy correlated significantly with pathologic complete response (pCR) and distant metastasis in triple-negative breast cancer (TNBC), according to a study...
(MedPage Today) -- Surging interest in the purported benefits of psychedelic drugs has given rise to books, documentaries, and conferences dedicated to the mind-altering substances. Now add one more business to the list: psychedelic retreats....